Heidelberg Pharma AG

DB:HPHA Stock Report

Market Cap: €103.9m

Heidelberg Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Andreas Pahl

Chief executive officer

€450.7k

Total compensation

CEO salary percentage53.3%
CEO tenureless than a year
CEO ownershipn/a
Management average tenure1.7yrs
Board average tenure12.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Andreas Pahl's remuneration changed compared to Heidelberg Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Aug 31 2024n/an/a

-€19m

May 31 2024n/an/a

-€13m

Feb 29 2024n/an/a

-€18m

Nov 30 2023€451k€240k

-€20m

Aug 31 2023n/an/a

-€22m

May 31 2023n/an/a

-€27m

Feb 28 2023n/an/a

-€19m

Nov 30 2022€328k€240k

-€20m

Aug 31 2022n/an/a

-€21m

May 31 2022n/an/a

-€22m

Feb 28 2022n/an/a

-€27m

Nov 30 2021€442k€240k

-€26m

Aug 31 2021n/an/a

-€25m

May 31 2021n/an/a

-€22m

Feb 28 2021n/an/a

-€20m

Nov 30 2020€295k€207k

-€18m

Aug 31 2020n/an/a

-€17m

May 31 2020n/an/a

-€15m

Feb 29 2020n/an/a

-€12m

Nov 30 2019€288k€200k

-€10m

Aug 31 2019n/an/a

-€10m

May 31 2019n/an/a

-€11m

Feb 28 2019n/an/a

-€12m

Nov 30 2018€286k€200k

-€12m

Aug 31 2018n/an/a

-€11m

May 31 2018n/an/a

-€11m

Feb 28 2018n/an/a

-€11m

Nov 30 2017€241k€171k

-€11m

Compensation vs Market: Andreas's total compensation ($USD469.29K) is about average for companies of similar size in the German market ($USD471.55K).

Compensation vs Earnings: Andreas's compensation has increased whilst the company is unprofitable.

CEO

Andreas Pahl

less than a year

Tenure

€450,663

Compensation

Prof. Dr. Andreas Pahl is Chief Executive Officer & Spokesman of the Executive Board at Heidelberg Pharma AG since February 1, 2024 and had been its Chief Scientific Officer and Member of the Executive Man...

Leadership Team

NamePositionTenureCompensationOwnership
Andreas Pahl
CEO & Spokesman of the Executive Boardless than a year€450.66kno data
Walter Miller
Chief Financial Officer1.5yrs€398.63kno data
Jorg Kemkowski
Chief Operating Officer1.8yrsno datano data
Sylvia Wimmer
Director Corporate Communicationno datano datano data
Andras Strassz
Chief Medical Officer3.7yrsno datano data
George Badescu
Chief Business Officerno datano datano data

1.7yrs

Average Tenure

Experienced Management: HPHA's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Friedrich von Bohlen und Halbach
Member of the Supervisory Board19.6yrs€18.00kno data
Georg Baur
Deputy Chairman of the Supervisory Board24.8yrs€38.00kno data
Christof Hettich
Chairman of Supervisory Board14.5yrs€49.50kno data
Birgit Kudlek
Member of the Supervisory Board12.5yrs€21.75kno data
Mathias Hothum
Deputy Chairman of Supervisory Board9.3yrs€39.00kno data
Dongzhou Liu
Member of Supervisory Board2.4yrs€21.00kno data
Yan Xia
Member of Supervisory Board1.5yrs€9.96kno data

12.5yrs

Average Tenure

59.5yo

Average Age

Experienced Board: HPHA's board of directors are seasoned and experienced ( 12.5 years average tenure).